US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Helix Acquisition Corp. II

10.75

+0.02000.19%

Post-market: 10.750.00000.00%16:00 EDT

Volume:124.72K

Turnover:1.34M

Market Cap:252.72M

PE:42.14

High:10.75

Open:10.75

Low:10.69

Close:10.73

Loading ...

Overview Company News Filings

Helix Acquisition Corp. II Merger with BridgeBio Approved

Helix Acquisition Corp. Ii and BridgeBio Oncology Therapeutics Announce Effectiveness of Registration Statement for Proposed Business Combination

THOMSON REUTERS

Press Release: Helix Acquisition Corp. II and BridgeBio Oncology Therapeutics Announce Effectiveness of Registration Statement for Proposed Business Combination

Helix Acquisition to Merge With BridgeBio Oncology Therapeutics

MT Newswires Live

Helix Acquisition Corp Ii - Combined Company to Be Listed on Nasdaq Under Ticker Bbot

THOMSON REUTERS

Helix Acquisition Corp Ii - Upon Deal Close, Bbot Expects Access to About $550 Mln in Cash

THOMSON REUTERS

BridgeBio Oncology Therapeutics (Bbot) and Helix Acquisition Corp. Ii Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of Ras and Pi3kΑ-Targeting Medicines

THOMSON REUTERS

Helix Acquisition Corp Ii - Total Proceeds Expected to Be $450 Million From Deal

THOMSON REUTERS

BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Targeting Medicines

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/HLXB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HLXB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HLXB\",,,,,undefined,":{"symbol":"HLXB","market":"US","secType":"STK","nameCN":"Helix Acquisition Corp. II","latestPrice":10.75,"timestamp":1753214400000,"preClose":10.73,"halted":0,"volume":124724,"hourTrading":{"tag":"盘后","latestPrice":10.75,"preClose":10.75,"latestTime":"16:00 EDT","volume":4,"amount":43,"timestamp":1753214402179},"delay":0,"floatShares":5679040,"shares":23509000,"eps":0.255099,"marketStatus":"Not Yet Opened","change":0.02,"latestTime":"07-22 16:00:00 EDT","open":10.75,"high":10.75,"low":10.69,"amount":1337442.5175,"amplitude":0.005592,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.255099,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753257600000},"marketStatusCode":0,"adr":0,"listingDate":1707454800000,"exchange":"NASDAQ","adjPreClose":10.73,"postHourTrading":{"tag":"盘后","latestPrice":10.75,"preClose":10.75,"latestTime":"16:00 EDT","volume":4,"amount":43,"timestamp":1753214402179},"volumeRatio":0.70059},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HLXB\",,,,,undefined,":{"symbol":"HLXB","floatShares":5679040,"roa":"-0.55%","roe":"--","lyrEps":0.359083,"volumeRatio":0.70059,"shares":23509000,"dividePrice":0,"high":10.75,"amplitude":0.005592,"preClose":10.73,"low":10.69,"week52Low":10.28,"pbRate":"1.35","week52High":11.59,"institutionHeld":0,"latestPrice":10.75,"eps":0.255099,"divideRate":0,"volume":124724,"delay":0,"ttmEps":0.255099,"open":10.75,"prevYearClose":10.5,"prevWeekClose":10.75,"prevMonthClose":10.62,"prevQuarterClose":10.62,"fiveDayClose":10.715,"twentyDayClose":10.7,"sixtyDayClose":10.8},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HLXB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2550955824","title":"Helix Acquisition Corp. II Merger with BridgeBio Approved","url":"https://stock-news.laohu8.com/highlight/detail?id=2550955824","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550955824?lang=en_us&edition=fundamental","pubTime":"2025-07-11 20:18","pubTimestamp":1752236287,"startTime":"0","endTime":"0","summary":"Helix Acquisition Corp. II Class A ( ($HLXB) ) just unveiled an announcement. On July 11, 2025, Helix Acquisition Corp. II and BridgeBio Oncology T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/helix-acquisition-corp-ii-merger-with-bridgebio-approved?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/helix-acquisition-corp-ii-merger-with-bridgebio-approved?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HLXB"],"gpt_icon":0},{"id":"2550935958","title":"Helix Acquisition Corp. Ii and BridgeBio Oncology Therapeutics Announce Effectiveness of Registration Statement for Proposed Business Combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2550935958","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550935958?lang=en_us&edition=fundamental","pubTime":"2025-07-11 19:43","pubTimestamp":1752234180,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250711:nTUA38WF5T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HLXB"],"gpt_icon":0},{"id":"2550958958","title":"Press Release: Helix Acquisition Corp. II and BridgeBio Oncology Therapeutics Announce Effectiveness of Registration Statement for Proposed Business Combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2550958958","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550958958?lang=en_us&edition=fundamental","pubTime":"2025-07-11 19:43","pubTimestamp":1752234180,"startTime":"0","endTime":"0","summary":"Extraordinary General Meeting of Helix Shareholders Scheduled for August 4, 2025. SOUTH SAN FRANCISCO & BOSTON, July 11, 2025  -- Helix Acquisition Corp. II  , a special purpose acquisition company  sponsored by Cormorant Asset Management, and TheRas, Inc.  , a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3K<ALPHA> malignancies, today announced that the registration statement on Form S-4  , filed by Helix and BBOT, relating to the previously-announced business combination among Helix, BBOT, and the other parties thereto , has been declared effective by the U.S. Securities and Exchange Commission .The parties anticipate that the Business Combination will close in August 2025, subject to satisfaction of the conditions to the closing of the Business Combination.BridgeBio Oncology Therapeutics  is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HLXB","BK4139","BK4539","BK4007","LENZ"],"gpt_icon":0},{"id":"2514320523","title":"Helix Acquisition to Merge With BridgeBio Oncology Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320523","media":"MT Newswires Live","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514320523?lang=en_us&edition=fundamental","pubTime":"2025-02-28 22:36","pubTimestamp":1740753360,"startTime":"0","endTime":"0","summary":"Helix Acquisition Corp. II  and TheRas, which does business as BridgeBio Oncology Therapeutics, said Friday they have agreed to merge to form biopharmaceutical company BridgeBio Oncology Therapeutics.The combined company is expected to have an implied pro forma equity value of about $949 million at closing based on a share price of $10.36 and no redemptions of Helix shares, and will be listed on Nasdaq with the ticker symbol BBOT, according to a joint statement.The transaction includes about $196 million from Helix's trust account and $260 million in private investment in public equity funding from Cormorant Asset Management, with contributions from other institutional investors, the companies said.Upon completion of the deal expected in Q3, BridgeBio Oncology expects to have access to about $550 million in cash, including $100 million in existing funds, assuming no redemptions by Helix shareholders, the companies said.Net proceeds from the deal will support BridgeBio Oncology's three ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4139","BBIO","BK4505","BK4588","HLXB","LENZ"],"gpt_icon":0},{"id":"2514932614","title":"Helix Acquisition Corp Ii - Combined Company to Be Listed on Nasdaq Under Ticker Bbot","url":"https://stock-news.laohu8.com/highlight/detail?id=2514932614","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514932614?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:49","pubTimestamp":1740746940,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nTUABHWMM8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HLXB"],"gpt_icon":0},{"id":"2514326707","title":"Helix Acquisition Corp Ii - Upon Deal Close, Bbot Expects Access to About $550 Mln in Cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2514326707","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514326707?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:49","pubTimestamp":1740746940,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nTUABHWMM8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HLXB"],"gpt_icon":0},{"id":"2514326176","title":"BridgeBio Oncology Therapeutics (Bbot) and Helix Acquisition Corp. Ii Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of Ras and Pi3kΑ-Targeting Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2514326176","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514326176?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:49","pubTimestamp":1740746940,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nTUABHWMM8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HLXB"],"gpt_icon":0},{"id":"2514326123","title":"Helix Acquisition Corp Ii - Total Proceeds Expected to Be $450 Million From Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2514326123","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514326123?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:49","pubTimestamp":1740746940,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nTUABHWMM8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HLXB"],"gpt_icon":0},{"id":"2514329905","title":"BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Targeting Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2514329905","media":"Business Wire","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514329905?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:49","pubTimestamp":1740746940,"startTime":"0","endTime":"0","summary":"Total proceeds, assuming no redemptions, are expected to be $450 million, combining funds held in the Helix Acquisition Corp. II trust account and a private investment in public equity  financing. Leading institutional investors commit approximately $260 million through a PIPE led by Cormorant Asset Management. Business combination is expected to be completed in the third quarter of 2025. The combined entity will be named BridgeBio Oncology Therapeutics  and will be advancing a next-generation pipeline of therapies for patients with RAS and PI3Kα malignancies. Net proceeds from the transaction are expected to provide BBOT with the capital needed to accelerate the development of three lead programs: BBO-8520, BBO-10203, and BBO-11818. BBO-8520 is a direct inhibitor of KRASG12C in both the \"ON\" and \"OFF\" states and is currently being evaluated in the Phase 1 ONKORAS-101 trial  for patients with KRASG12C mutant non-small cell lung cancer. BBO-10203 is an orally bioavailable small molecule","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bridgebio-oncology-therapeutics-bbot-helix-124900685.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MDCO","HLXB","BK4139","PIPE","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HLXB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"HLXB","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-14","symbol":"HLXB","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HLXB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HLXB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HLXB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HLXB","date":"2025-07-21","current":42.038471,"percent":0.935673,"low":-6230.798475,"twenty":-5920.668234,"median":-5751.506284,"eighty":33.378737,"high":42.625054,"avg":-4291.046037,"sd":2586.346179,"marketCap":252721750},"quantilePoints":[{"date":"2024-02-09","current":-4887.028687,"twenty":-4887.028687,"median":-4887.028687,"eighty":-4887.028687,"marketCap":203750000},{"date":"2024-02-16","current":-5790.439413,"twenty":-5686.648518,"median":-5111.832006,"eighty":-4979.882232,"marketCap":241415000},{"date":"2024-02-23","current":-5769.560107,"twenty":-5703.230836,"median":-5637.684447,"eighty":-5050.255445,"marketCap":240544500},{"date":"2024-03-01","current":-5692.632639,"twenty":-5742.086012,"median":-5686.648518,"eighty":-5138.221961,"marketCap":237337240},{"date":"2024-03-08","current":-5681.148446,"twenty":-5742.086012,"median":-5686.893169,"eighty":-5523.72719,"marketCap":236858441},{"date":"2024-03-15","current":-5709.117097,"twenty":-5720.106735,"median":-5686.648518,"eighty":-5628.892737,"marketCap":238024510},{"date":"2024-03-22","current":-5659.663724,"twenty":-5714.611916,"median":-5681.395723,"eighty":-5628.892737,"marketCap":235962700},{"date":"2024-03-28","current":-5666.037705,"twenty":-5714.611916,"median":-5668.345534,"eighty":-5632.189629,"marketCap":236228444},{"date":"2024-04-05","current":-5681.643001,"twenty":-5714.611916,"median":-5670.653363,"eighty":-5632.189629,"marketCap":236879060},{"date":"2024-04-12","current":-5681.643001,"twenty":-5714.611916,"median":-5681.395723,"eighty":-5632.189629,"marketCap":236879060},{"date":"2024-04-19","current":-5681.643001,"twenty":-5714.611916,"median":-5681.643001,"eighty":-5635.48652,"marketCap":236879060},{"date":"2024-04-26","current":-5654.168905,"twenty":-5714.611916,"median":-5681.643001,"eighty":-5632.189629,"marketCap":235733610},{"date":"2024-05-03","current":-5681.643001,"twenty":-5711.315025,"median":-5681.643001,"eighty":-5632.189629,"marketCap":236879060},{"date":"2024-05-10","current":-5681.643001,"twenty":-5699.226422,"median":-5681.643001,"eighty":-5632.189629,"marketCap":236879060},{"date":"2024-05-17","current":-5681.643001,"twenty":-5689.335748,"median":-5681.643001,"eighty":-5632.189629,"marketCap":236879060},{"date":"2024-05-24","current":-5637.684448,"twenty":-5687.13782,"median":-5681.643001,"eighty":-5632.189629,"marketCap":235046340},{"date":"2024-05-31","current":-5637.684448,"twenty":-5687.13782,"median":-5681.643001,"eighty":-5632.189629,"marketCap":235046340},{"date":"2024-06-07","current":-5785.338674,"twenty":-5687.13782,"median":-5681.148446,"eighty":-5634.387557,"marketCap":241202340},{"date":"2024-06-14","current":-5774.061211,"twenty":-5705.820205,"median":-5681.643001,"eighty":-5637.684448,"marketCap":240732160},{"date":"2024-06-21","current":-5751.506284,"twenty":-5714.611916,"median":-5681.643001,"eighty":-5637.684448,"marketCap":239791800},{"date":"2024-06-28","current":-5774.061211,"twenty":-5714.611916,"median":-5681.643001,"eighty":-5637.684448,"marketCap":240732160},{"date":"2024-07-05","current":-5751.506284,"twenty":-5742.086012,"median":-5681.643001,"eighty":-5637.684448,"marketCap":239791800},{"date":"2024-07-12","current":-5774.061211,"twenty":-5751.506284,"median":-5681.643001,"eighty":-5637.684448,"marketCap":240732160},{"date":"2024-07-15","current":-5751.506284,"twenty":-5751.506284,"median":-5681.643001,"eighty":-5637.684448,"marketCap":239791800},{"date":"2024-08-02","current":-5830.448527,"twenty":-5751.506284,"median":-5681.643001,"eighty":-5637.684448,"marketCap":243083060},{"date":"2024-08-09","current":-5864.280917,"twenty":-5757.145016,"median":-5681.643001,"eighty":-5637.684448,"marketCap":244493600},{"date":"2024-08-16","current":-5864.280917,"twenty":-5774.061211,"median":-5681.643001,"eighty":-5637.684448,"marketCap":244493600},{"date":"2024-08-23","current":-5867.100283,"twenty":-5774.061211,"median":-5681.643001,"eighty":-5637.684448,"marketCap":244611145},{"date":"2024-08-30","current":-5813.532332,"twenty":-5785.338674,"median":-5684.14576,"eighty":-5637.684448,"marketCap":242377790},{"date":"2024-09-06","current":-5824.809796,"twenty":-5794.145447,"median":-5687.13782,"eighty":-5637.684448,"marketCap":242847970},{"date":"2024-09-13","current":-5864.280917,"twenty":-5820.29881,"median":-5687.13782,"eighty":-5637.684448,"marketCap":244493600},{"date":"2024-09-20","current":-5892.474575,"twenty":-5836.087259,"median":-5700.874868,"eighty":-5637.684448,"marketCap":245669050},{"date":"2024-09-27","current":-5892.474575,"twenty":-5862.025425,"median":-5714.611916,"eighty":-5644.278231,"marketCap":245669050},{"date":"2024-10-04","current":-5878.377746,"twenty":-5864.280917,"median":-5714.611916,"eighty":-5654.168905,"marketCap":245081325},{"date":"2024-10-11","current":-5920.668234,"twenty":-5864.280917,"median":-5742.086012,"eighty":-5654.168905,"marketCap":246844500},{"date":"2024-10-18","current":-5841.725991,"twenty":-5864.280917,"median":-5742.086012,"eighty":-5654.168905,"marketCap":243553240},{"date":"2024-10-25","current":-5915.029502,"twenty":-5864.280917,"median":-5751.506284,"eighty":-5656.366833,"marketCap":246609410},{"date":"2024-10-31","current":-5920.668234,"twenty":-5864.280917,"median":-5751.506284,"eighty":-5659.663724,"marketCap":246844500},{"date":"2024-11-08","current":-5892.474575,"twenty":-5864.280917,"median":-5754.32565,"eighty":-5660.762688,"marketCap":245669050},{"date":"2024-11-15","current":-5934.765063,"twenty":-5866.53641,"median":-5762.783747,"eighty":-5665.334376,"marketCap":247432225},{"date":"2024-11-22","current":-5875.558381,"twenty":-5875.558381,"median":-5774.061211,"eighty":-5666.960837,"marketCap":244963780},{"date":"2024-11-29","current":-5892.474575,"twenty":-5875.558381,"median":-5774.061211,"eighty":-5670.653363,"marketCap":245669050},{"date":"2024-12-06","current":-5892.474575,"twenty":-5878.377746,"median":-5774.061211,"eighty":-5670.653363,"marketCap":245669050},{"date":"2024-12-13","current":-6005.249208,"twenty":-5892.418186,"median":-5782.519308,"eighty":-5670.653363,"marketCap":250370850},{"date":"2024-12-20","current":-6089.830183,"twenty":-5892.474575,"median":-5785.338674,"eighty":-5676.148182,"marketCap":253897200},{"date":"2024-12-27","current":-5869.919649,"twenty":-5892.474575,"median":-5796.616137,"eighty":-5680.148393,"marketCap":244728690},{"date":"2025-01-03","current":-6196.966085,"twenty":-5892.474575,"median":-5813.532332,"eighty":-5681.445179,"marketCap":258363910},{"date":"2025-01-10","current":-6163.133695,"twenty":-5892.474575,"median":-5824.809796,"eighty":-5681.643001,"marketCap":256953370},{"date":"2025-01-17","current":-5977.05555,"twenty":-5892.474575,"median":-5836.087259,"eighty":-5681.643001,"marketCap":249195400},{"date":"2025-01-24","current":-5926.306965,"twenty":-5901.496546,"median":-5836.087259,"eighty":-5681.643001,"marketCap":247079590},{"date":"2025-01-31","current":-6033.386477,"twenty":-5915.029502,"median":-5836.087259,"eighty":-5681.643001,"marketCap":251543949},{"date":"2025-02-07","current":-6089.773794,"twenty":-5920.668234,"median":-5836.143625,"eighty":-5681.643001,"marketCap":253894849},{"date":"2025-02-14","current":-6033.442867,"twenty":-5920.668234,"median":-5841.725991,"eighty":-5681.643001,"marketCap":251546300},{"date":"2025-02-21","current":-6033.442867,"twenty":-5920.668234,"median":-5858.642186,"eighty":-5681.643001,"marketCap":251546300},{"date":"2025-02-28","current":-6089.830183,"twenty":-5926.306965,"median":-5864.280917,"eighty":-5681.643001,"marketCap":253897200},{"date":"2025-03-07","current":-6084.191452,"twenty":-5940.403794,"median":-5864.280917,"eighty":-5681.643001,"marketCap":253662110},{"date":"2025-03-14","current":33.378737,"twenty":-5948.861892,"median":-5864.280917,"eighty":-5681.643001,"marketCap":253662110},{"date":"2025-03-21","current":33.193127,"twenty":-5940.403794,"median":-5864.280917,"eighty":-5681.643001,"marketCap":252251570},{"date":"2025-03-28","current":33.254997,"twenty":-5934.765063,"median":-5858.642186,"eighty":-5676.148182,"marketCap":252721750},{"date":"2025-04-04","current":33.595281,"twenty":-5934.765063,"median":-5841.725991,"eighty":-5666.037705,"marketCap":255307740},{"date":"2025-04-11","current":33.100323,"twenty":-5931.945697,"median":-5836.143625,"eighty":-5654.168905,"marketCap":251546300},{"date":"2025-04-17","current":33.378737,"twenty":-5927.434711,"median":-5836.087259,"eighty":-5650.872014,"marketCap":253662110},{"date":"2025-04-25","current":33.409672,"twenty":-5926.306965,"median":-5836.087259,"eighty":-5637.684448,"marketCap":253897200},{"date":"2025-05-02","current":33.564346,"twenty":-5926.306965,"median":-5833.267893,"eighty":-5637.684448,"marketCap":255072650},{"date":"2025-05-09","current":33.564346,"twenty":-5926.306965,"median":-5813.532332,"eighty":-5636.585484,"marketCap":255072650},{"date":"2025-05-16","current":33.564346,"twenty":-5921.79598,"median":-5799.435503,"eighty":-5632.189629,"marketCap":255072650},{"date":"2025-05-23","current":42.31221,"twenty":-5920.668234,"median":-5785.338674,"eighty":-5631.090665,"marketCap":254367380},{"date":"2025-05-30","current":42.233999,"twenty":-5920.668234,"median":-5785.338674,"eighty":-5619.002062,"marketCap":253897200},{"date":"2025-06-06","current":42.585949,"twenty":-5920.668234,"median":-5776.880576,"eighty":-5032.662142,"marketCap":256013010},{"date":"2025-06-13","current":42.351315,"twenty":-5920.668234,"median":-5774.061211,"eighty":32.988957,"marketCap":254602470},{"date":"2025-06-20","current":42.449079,"twenty":-5920.668234,"median":-5774.061211,"eighty":33.137445,"marketCap":255190195},{"date":"2025-06-27","current":41.647415,"twenty":-5920.668234,"median":-5766.171927,"eighty":33.224062,"marketCap":250370850},{"date":"2025-07-03","current":41.60831,"twenty":-5920.668234,"median":-5757.145016,"eighty":33.254997,"marketCap":250135760},{"date":"2025-07-11","current":41.697861,"twenty":-5920.668234,"median":-5751.506284,"eighty":33.316867,"marketCap":250674116},{"date":"2025-07-18","current":41.842943,"twenty":-5920.668234,"median":-5751.506284,"eighty":33.366363,"marketCap":251546300},{"date":"2025-07-21","current":42.038471,"twenty":-5920.668234,"median":-5751.506284,"eighty":33.378737,"marketCap":252721750}],"updateTime":1753248263043}}}